ENTRY       D08481                      Drug
NAME        Rilmazafone (INN)
FORMULA     C21H20Cl2N6O3
EXACT_MASS  474.0974
MOL_WEIGHT  475.3279
CLASS       Neuropsychiatric agent
             DG01835  Benzodiazepine sedative-hypnotics
             DG03202  Hypnotic
             DG01567  GABA-A receptor agonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02970  CES substrate
REMARK      Chemical structure group: DG01307
            Product (DG01307): D01564<JP>
EFFICACY    Hypnotic
COMMENT     Benzodiazepines
TARGET      GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]
  PATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction
            hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse
METABOLISM  Enzyme: CES [HSA:1066 8824 23491 221223], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07032  Hypnotics
            map07230  GABA-A receptor agonists/antagonists
BRITE       Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01835  Benzodiazepine sedative-hypnotics
               DG01307  Rilmazafone
                D08481  Rilmazafone
              DG03202  Hypnotic
               DG01307  Rilmazafone
                D08481  Rilmazafone
              DG01567  GABA-A receptor agonist
               DG01307  Rilmazafone
                D08481  Rilmazafone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01307  Rilmazafone
                 D08481  Rilmazafone
              DG02970  CES substrate
               DG01307  Rilmazafone
                D08481  Rilmazafone
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               GABA (ionotropic)
                GABR
                 D08481  Rilmazafone (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08481
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01835  Benzodiazepine sedative-hypnotics
               DG01307  Rilmazafone
              DG03202  Hypnotic
               DG01307  Rilmazafone
              DG01567  GABA-A receptor agonist
               DG01307  Rilmazafone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01307  Rilmazafone
              DG02970  CES substrate
               DG01307  Rilmazafone
DBLINKS     CAS: 99593-25-6
            PubChem: 96025167
            LigandBox: D08481
            NIKKAJI: J22.811G
ATOM        32
            1   N4y N    24.7800  -18.4100
            2   C8y C    23.5900  -19.2500
            3   N5x N    24.0100  -20.5800
            4   C8y C    25.4100  -20.5800
            5   N5x N    25.9000  -19.2500
            6   C8y C    24.7800  -17.0100
            7   C8y C    25.9700  -16.3100
            8   C8x C    25.9700  -14.9100
            9   C8y C    24.7800  -14.2100
            10  C8x C    23.5200  -14.9100
            11  C8x C    23.5200  -16.3100
            12  C1b C    22.4000  -18.5500
            13  C5a C    26.2500  -21.7000
            14  O5a O    25.6900  -23.0300
            15  C1a C    28.4900  -22.8900
            16  N1c N    27.6500  -21.7000
            17  C1a C    28.2100  -20.4400
            18  X   Cl   24.7800  -12.8100
            19  C5a C    27.1600  -17.0100
            20  O5a O    27.1600  -18.4100
            21  C8y C    28.3500  -16.3800
            22  C8x C    29.6100  -17.0800
            23  C8x C    30.8000  -16.3800
            24  C8x C    30.8000  -14.9800
            25  C8x C    29.6100  -14.2800
            26  C8y C    28.3500  -14.9800
            27  N1b N    21.2100  -19.3200
            28  C5a C    19.9500  -18.6200
            29  O5a O    19.9500  -17.2200
            30  C1b C    18.7600  -19.3900
            31  N1a N    17.5700  -18.6900
            32  X   Cl   27.1600  -14.2800
BOND        34
            1     4  13 1
            2     1   6 1
            3    16  17 1
            4     9  18 1
            5     7  19 1
            6    19  20 2
            7     2   3 2
            8    19  21 1
            9     1   2 1
            10    3   4 1
            11    4   5 2
            12    5   1 1
            13    2  12 1
            14   21  22 2
            15   22  23 1
            16   23  24 2
            17   24  25 1
            18   25  26 2
            19   26  21 1
            20    6   7 2
            21   12  27 1
            22    7   8 1
            23   27  28 1
            24    8   9 2
            25   28  29 2
            26    9  10 1
            27   28  30 1
            28   10  11 2
            29   30  31 1
            30   11   6 1
            31   26  32 1
            32   13  14 2
            33   15  16 1
            34   16  13 1
///
